Healthcare & Life Sciences

Nimble Therapeutics

acquiredacquired
acquired
Stage
1
Investors

About

Nimble Therapeutics applies massively parallel chemical synthesis to accelerate drug discovery and development, focusing on innovative medicines primarily in immunology.

Explore Nimble Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.